Compositions for activating pyruvate kinase
First Claim
Patent Images
1. A composition comprising compound 1, or a pharmaceutically acceptable salt thereof:
2 Assignments
0 Petitions
Accused Products
Abstract
Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).
-
Citations
10 Claims
- 1. A composition comprising compound 1, or a pharmaceutically acceptable salt thereof:
- 4. A method of treating a patient diagnosed with a pyruvate kinase-related medical condition, the method comprising administering to the patient in need thereof a therapeutically effective amount of pharmaceutical composition comprising a compound 1-(5-((3,4-Dihydro-2H-benzo[b][1,4]oxazin-6-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-2-hydroxy-2-methylpropan-1-one, or a pharmaceutically acceptable salt thereof.
- 7. A composition comprising compound 1 obtained by a process comprising the step of converting compound 4 into compound 1 in a reaction described as Step 4:
Specification